Decreasing the toxicity of an ibuprofen salt |
| I claim: 1. A method of decreasing the toxicity of a salt of ibuprofen by combining the salt with ... |
|
5,6,7,8 Tetrahydroquinoline derivatives |
| I claim: 1. A compound of the formula ##SPC15## and the non-toxic acid addition salts thereof ... |
|
8-Carboxylester, and 8-carbamyl derivitives of 5,6,7,8-tetrahydroquinoline |
| We claim: 1. A compound of formula I l ##STR11## and acid addition salts thereof with ... |
|
Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine |
| What we claim is: 1. Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine from 2,2,4,4... |
|
8-Alkyl-5-oxo-5,8-dihydro-pyrido(2,3-d)pyrimidine-6-carboxylic acids and their preparation |
| We claim: 1. An 8-alkyl-5-oxo-5,8-dihydro-pyrido(2,3-d)-pyrimidine-6-carboxylic acid of the formula:... |
|
O-Alkyl-S-alkyl-O-[6-alkyl- or 6-halo-pyridazin-(3)-yl]-(thiono)thiol-phosphoric acid esters |
| We claim: 1. An O-ethyl-S-n-propyl -O-(6-substituted-pyridazin(3)-yl)-thiono thiolphosphoric acid ... |
|
Process for the preparation of imidazo [1,2-a] pyridines |
| What is claimed is: 1. A process for the preparation of a compound having the formula: ##STR6## ... |
|
Process for preparing silica-alumina |
| OF THE INVENTION The term "silica-alumina hydrogel" as used herein is defined as a coagulated ... |
|
Synergistic pesticidal compositions |
| OF THE INVENTION The fatty acids used according to the subject invention can be unsubstituted, or ... |
|
Method for improving cerebral circulation |
| This invention relates to a cerebral-circulation-metabolism-function-improving agent comprising a 2,... |
|
|
Process for manufacturing aromatic diamines
| Details |
|
Inventors: Bohm, Walter; Kritzler, Helmuth; Neumann, Lutz;
Assignee: Bayer Aktiengesellschaft (Leverkusen, DT)
Primary Examiner: Demers; Arthur P.
Assistant Examiner:
Attorney, Agent or Firm: Burgess, Dinklage & Sprung
Aromatic diamines having the formula ##STR1## wherein R is alkyl or alkoxy having up to 6 carbon atoms are prepared by treating dinitro compounds having the formula ##STR2## wherein R is as previously defined, with hydrogen in the presence of one or more noble metals from the platinum or palladium groups as catalysts, optionally on catalyst supports, and in the presence of optionally substituted aniline as the solvent. The catalyst is generally used in amounts of 0.0005 to 0.1% by weight based on the amount of dinitro compound employed. |
|
DETAILED DESCRIPTION What is claimed is: 1. Process for preparing an aromatic diamine having the formula ##STR5## wherein R is an alkyl or alkoxy group having up to 6 carbon atoms which comprises contacting in the presence of a solvent selected from the group consisting of aniline, O-toluidine and m-toluidine a dinitro compound of the formula ##STR6## wherein R is as defined above with hydrogen in the presence of a catalyst containing at least one metal of period 5 or 6 of Group VII of the Periodic Table, said catalyst being present in an amount of 0. 0005 to 0. 1% by weight metal, based upon the amount of dinitro compound being reacted. 2. Process of claim 1 wherein the metal is palladium. 3. Process of claim 1 wherein the metal is palladium and said palladium is deposited on active charcoal. 4. Process of claim 1 wherein the amount of catalyst is 0. 005 to 0. 02% by weight of nobel metal based on the amount of dinitro compound employed. 5. Process of claim 1 wherein the solvent is selected from the group of, O-toluidine and m-toluidine. 6. Process according to claim 1 wherein the solvent is O-toluidine. 7. Process according to claim 1 wherein the solvent is m-toluidine.
Description:
BACKGROUND This invention relates to a process for the manufacture of aromatic diamines by catalytic hydrogenation of the corresponding dinitro compounds. The catalytic reduction of dinitro compounds is a problem which has remained unsolved in many cases. The processes known in individual cases can in general not be applied with equal success to other starting compounds (German Pat. No. 948,784). SUMMARY It has now been found that aromatic diamines of the formula ##STR3## in which R denotes a alkyl or alkoxy radical with up to 6 C atoms Are obtained in good yield when dinitro compounds of the formula ##STR4## in which R has the abovementioned meaning are treated with hydrogen in the presence of one or more noble metals of periods 5 and 6 of Group VIII of the Periodic Table (as shown on the end page of "Advanced Inorganic Chemistry," Cotton & Wilkinson, 1966, 2nd Edition, Interscience), as the catalyst and of optionally substituted aniline as the solvent
|
| Related patents |
|
|
Antiestrogens and their use in treatment of menopause and osteoporosis
I claim: 1. A method of treating and preventing bone tissue loss or osteoporosis in a patient, comprising administering a true antiestrogen selected from the group ...
|
|
|
Pharmaceutical combination for treatment of bone-wasting diseases
What is claimed is: 1. A pharmaceutical composition for increasing bone mass and preventing loss of bone mass, comprising: effective amounts of a fluoride source capable ...
|
|
|
IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone
The aim of the present invention was therefore to provide for a method for treating diseases of the skeleton caused by bone loss. Surprisingly, the inventors have found ...
|
|
|
1-hydroxy-3-(N-methyl-N-propylamino)propane-1,1-diphosphonic acid, pharmaceutical compositions and methods of use
What is claimed is: 1. A diphosphonate compound of the formula ##STR9## wherein R is hydrogen, and the pharmacologically acceptable salts thereof. 2. A pharmaceutical ...
|
|
|
Two phase antiperspirant compositions
OF THE INVENTION The two-phase antiperspirant stick compositions of the present invention comprise A) an antiperspirant phase and B) a gel phase contiguous to the ...
|
|
|
Water soluble platinum complexes of novel malonate derivatives
OF THE INVENTION The compounds of this invention may be prepared according to the following reaction schemes. ##STR8## According to Flowchart I dichloroethyl ether (1) ...
|
|
|
Phenyl-thiazepinones as calcium regulating agents
OF THE INVENTION As used herein, the term "lower alkyl" denotes a straight or branched-chain alkyl group containing 1 to 4 carbon atoms, for example, methyl, ethyl, ...
|
|
|
Fibrinogen receptor antagonists
OF THE INVENTION Compounds of the invention are cyclic fibrinogen receptor antagonists which inhibit fibrinogen induced platelet aggregation These compounds are ...
|
|
|
Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
OF THE INVENTION Description of the Preferred Embodiment In accordance with the present invention, biological and pharmaceutical products are pasteurized in the ...
|
|
|
Cryoprotective reagents in freeze-drying membranes
What is claimed is: 1. A composition for the protection of phosphoglyceride-containing biological or synthetic membranes from the disruptive effects of freezing, thawing,...
|
|
|